Atıf Formatları
Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

T. DEMİRER Et Al. , "Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation," 2019 American Society of Clinical Oncology (ASCO) Annual Meeting , 2019

DEMİRER, T. Et Al. 2019. Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation. 2019 American Society of Clinical Oncology (ASCO) Annual Meeting .

DEMİRER, T., CENGİZ SEVAL, G., TOPRAK, S. K., CİVRİZ BOZDAĞ, S., YÜKSEL, M., TOPÇUOĞLU, P., ... ARSLAN, Ö.(2019). Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation . 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

DEMİRER, TANER Et Al. "Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation," 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, 2019

DEMİRER, TANER Et Al. "Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation." 2019 American Society of Clinical Oncology (ASCO) Annual Meeting , 2019

DEMİRER, T. Et Al. (2019) . "Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation." 2019 American Society of Clinical Oncology (ASCO) Annual Meeting .

@conferencepaper{conferencepaper, author={TANER DEMİRER Et Al. }, title={Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation}, congress name={2019 American Society of Clinical Oncology (ASCO) Annual Meeting}, city={}, country={}, year={2019}}